Imaging and Biomarker Approaches to HCC Surveillance
Piyush Nathani, Amit G. Singal – 4 August 2021
Diagnosis and Treatment of Alcohol‐Associated Liver Disease: A Patient‐Friendly Summary of the 2019 AASLD Guidelines
Madeline Bertha, Gina Choi, Jessica Mellinger – 4 August 2021
Enhancing Electronic Health Systems to End Transmission of Chronic Hepatitis B During COVID‐19: A Collaborative Approach
Eric Chak, Fresnia Vu, Julie Dang, Ulissa Smith, Susan Stewart, Karman Tam, Amy Beste‐Fong, Breanna Phelps, Ian Johnson, Miguel Suarez, Mary Pat Pauly, Moon S. Chen – 4 August 2021
Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
Tong Wu, Guijuan Luo, Qiuyu Lian, Chengjun Sui, Jing Tang, Yanjing Zhu, Bo Zheng, Zhixuan Li, Yani Zhang, Yangqianwen Zhang, Jinxia Bao, Ji Hu, Siyun Shen, Zhao Yang, Jianmin Wu, Kaiting Wang, Yan Zhao, Shuai Yang, Shan Wang, Xinyao Qiu, Wenwen Wang, Xuan Wu, Hongyang Wang, Jin Gu, Lei Chen – 2 August 2021
Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
Atsushi Hosui, Takashi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu – 2 August 2021 – We have reported that the plasma zinc concentration gradually decreases with the progression of fibrosis and is related to hepatocellular carcinoma (HCC) development.
Measuring the Toll of Acute Illness–Derived Frailty in Decompensated Cirrhosis
Matthew R. Kappus, Robert S. Rahimi, Michael L. Volk – 1 August 2021
A Digital Case‐Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure
Brooke Wyatt, Ponni V. Perumalswami, Anna Mageras, Mark Miller, Alyson Harty, Ning Ma, Chip A. Bowman, Francina Collado, Jihae Jeon, Lismeiry Paulino, Amreen Dinani, Douglas Dieterich, Li Li, Maxence Vandromme, Andrea D. Branch – 31 July 2021
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis
Jaime Bosch, Chuhan Chung, Oscar M. Carrasco‐Zevallos, Stephen A. Harrison, Manal F. Abdelmalek, Mitchell L. Shiffman, Don C. Rockey, Zahil Shanis, Dinkar Juyal, Harsha Pokkalla, Quang Huy Le, Murray Resnick, Michael Montalto, Andrew H. Beck, Ilan Wapinski, Ling Han, Catherine Jia, Zachary Goodman, Nezam Afdhal, Robert P. Myers, Arun J. Sanyal – 31 July 2021
Indocyanine Green Near‐Infrared Technology in Demarcating the Midplane During Pure Laparoscopic Donor Hepatectomy: Useful But Not Necessary
Vishal Chorasiya, Mohammed Qaleem, Kausar Makki, Arif Ali Khan, Furquan Ahmed, Ashish Singhal, Ajitabh Srivastava, Suvyl Rodricks, Amit Jha, Anil Agarwal, Piyush Srivastava, Vivek Vij – 30 July 2021
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis
Alexandra Shingina, Philip Vutien, Elizabeth Uleryk, Prakesh S. Shah, Eberhard Renner, Mamatha Bhat, Jill Tinmouth, Joseph Kim – 30 July 2021 – Living donor liver transplantation (LDLT) emerged in the 1980s as a viable alternative to scarce cadaveric organs for pediatric patients. However, pediatric waitlist mortality remains high. Long‐term outcomes of living and deceased donor liver transplantation (DDLT) are inconsistently described in the literature.